Tobacco smoke induces epithelial barrier dysfunction via receptor EphA2 signaling

American Journal of Physiology - Cell Physiology

Volumn 306, Issue 12, 2014, Pages

  Nasreen, Najmunnisa ^a,b   Khodayari, Nazli ^a,b   Sriram, Peruvemba S ^a,b   Patel, Jawaharlal ^a,b   Mohammed, Kamal A ^a,b  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

E cadherin; EphA2 receptor; Paxillin; Permeability; Tobacco smoke

Indexed keywords

EPHRIN A1; EPHRIN RECEPTOR A2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PAXILLIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TOBACCO SMOKE; UVOMORULIN;

ACTIN FILAMENT; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL CONTACT; CONTROLLED STUDY; DOWN REGULATION; ELECTRIC RESISTANCE; GENE SILENCING; HUMAN; HUMAN CELL; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY EPITHELIUM; RESPIRATORY EPITHELIUM BARRIER DYSFUNCTION; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; STRESS FIBER; UPREGULATION; WESTERN BLOTTING;

E-CADHERIN; EPHA2 RECEPTOR; PAXILLIN; PERMEABILITY; TOBACCO SMOKE;

ACTIN CYTOSKELETON; CADHERINS; CELL ADHESION; CELL COMMUNICATION; CELL LINE; EPHRIN-A1; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; RECEPTOR, EPHA2; SIGNAL TRANSDUCTION; TOBACCO SMOKE POLLUTION;

EID: 84902687124     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00415.2012     Document Type: Article

References (48)

1. Antony AB, Tepper RS, Mohammed KA. Cockroach extract antigen increases bronchial airway epithelial permeability. J Allergy Clin Immunol 110: 589-595, 2002.
2. Brannan JM, Dong W, Prudkin L, Behrens C, Lotan R, Bekele BN, Wistuba I, Johnson FM. Expression of the receptor tyrosine kinase EphA2 is increased in smokers and predicts poor survival in non-small cell lung cancer. Clin Cancer Res 15: 4423-4430, 2009.
3. Brantley-Sieders DM, Chen J. Eph receptor tyrosine kinases in angiogenesis: from development to disease. Angiogenesis 7: 17-28, 2004.
4. Brennan C, Monschau B, Lindberg R, Guthrie B, Drescher U, Bonhoeffer F, Holder N. Two Eph receptor tyrosine kinase ligands control axon growth and may be involved in the creation of the retinotectal map in the zebrafish. Development (Cambridge, England) 124: 655-664, 1997.
5. Calverley PM, Walker P. Chronic obstructive pulmonary disease. Lancet 362: 1053-1061, 2003.
6. Carpenter TC, Schroeder W, Stenmark KR, Schmidt EP. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury. Am J Respir Cell Mol Biol 46: 40-47, 2012.
7. Cercone MA, Schroeder W, Schomberg S, Carpenter TC. EphA2 receptor mediates increased vascular permeability in lung injury due to viral infection and hypoxia. Am J Physiol Lung Cell Mol Physiol 297: L856-L863, 2009.
8. Chang L, Karin M. Mammalian MAP kinase signalling cascades. Nature 410: 37-40, 2001.
9. Chauhan SD, Seggara G, Vo PA, Macallister RJ, Hobbs AJ, Ahluwalia A. Protection against lipopolysaccharide-induced endothelial dysfunction in resistance and conduit vasculature of iNOS knockout mice. FASEB J 17: 773-775, 2003.
10. Cohen AW, Carbajal JM, Schaeffer RC Jr. VEGF stimulates tyrosine phosphorylation of beta-catenin and small-pore endothelial barrier dysfunction. Am J Physiol Heart Circ Physiol 277: H2038-H2049, 1999.
11. Dodelet VC, Pasquale EB. Eph receptors and ephrin ligands: embryogenesis to tumorigenesis. Oncogene 19: 5614-5619, 2000.
12. English D, Cui Y, Siddiqui R, Patterson C, Natarajan V, Brindley DN, Garcia JG. Induction of endothelial monolayer permeability by phosphatidate. J Cell Biochem 75: 105-117, 1999.
13. Fang WB, Ireton RC, Zhuang G, Takahashi T, Reynolds A, Chen J. Overexpression of EPHA2 receptor destabilizes adherens junctions via a RhoA-dependent mechanism. J Cell Sci 121: 358-368, 2008.
14. Frisch SM, Francis H. Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol 124: 619-626, 1994.
15. Hafner C, Becker B, Landthaler M, Vogt T. Expression profile of Eph receptors and ephrin ligands in human skin and downregulation of EphA1 in nonmelanoma skin cancer. Mod Pathol 19: 1369-1377, 2006.
16. Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, Chen J. Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol 26: 4830-4842, 2006.
17. Ivanov AI, Parkos CA, Nusrat A. Cytoskeletal regulation of epithelial barrier function during inflammation. Am J Pathol 177: 512-524, 2010.
18. Ivanov AI, Romanovsky AA. Putative dual role of ephrin-Eph receptor interactions in inflammation. IUBMB Life 58: 389-394, 2006.
19. Keese CR, Giaever I. Substrate mechanics and cell spreading. Exp Cell Res 195: 528-532, 1991.
20. Kinch MS, Moore MB, Harpole DH Jr. Predictive value of the EphA2 receptor tyrosine kinase in lung cancer recurrence and survival. Clin Cancer Res 9: 613-618, 2003.
21. Koch S, Nusrat A. Dynamic regulation of epithelial cell fate and barrier function by intercellular junctions. Ann NY Acad Sci 1165: 220-227, 2009.
22. Lai YM, Mohammed KA, Nasreen N, Baumuratov A, Bellew BF, Antony VB. Induction of cell cycle arrest and apoptosis by BCG infection in cultured human bronchial airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 293: L393-L401, 2007.
23. Lin YG, Han LY, Kamat AA, Merritt WM, Landen CN, Deavers MT, Fletcher MS, Urbauer DL, Kinch MS, Sood AK. EphA2 overexpression is associated with angiogenesis in ovarian cancer. Cancer 109: 332-340, 2007.
24. Liu L, Yuan Y, Li F, Liu H. Relationship between apoptosis and E-cadherin expression in bronchial epithelium of smoking mouse. J Huazhong Univ Sci Technolog Med Sci 23: 216-218, 2003.
25. Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, Krausz T, Husain AN, Reid ME, Salgia R. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J Clin Pathol 64: 16-24, 2011.
26. Miao H, Wei BR, Peehl DM, Li Q, Alexandrou T, Schelling JR, Rhim JS, Sedor JR, Burnett E, Wang B. Activation of EphA receptor tyrosine kinase inhibits the Ras/MAPK pathway. Nat Cell Biol 3: 527-530, 2001.
27. Mochida-Nishimura K, Surewicz K, Cross JV, Hejal R, Templeton D, Rich EA, Toossi Z. Differential activation of MAP kinase signaling pathways and nuclear factor-kappaB in bronchoalveolar cells of smokers and nonsmokers. Mol Med 7: 177-185, 2001.
28. Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, Antony VB. Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 281: L119-L125, 2001.
29. Mohammed KA, Nasreen N, Hardwick J, Van Horn RD, Sanders KL, Antony VB. Mycobacteria induces pleural mesothelial permeability by downregulating beta-catenin expression. Lung 181: 57-66, 2003.
30. Mohammed KA, Nasreen N, Tepper RS, Antony VB. Cyclic stretch induces PlGF expression in bronchial airway epithelial cells via nitric oxide release. Am J Physiol Lung Cell Mol Physiol 292: L559-L566, 2007.
31. Mohammed KA, Wang X, Goldberg EP, Antony VB, Nasreen N. Silencing receptor EphA2 induces apoptosis and attenuates tumor growth in malignant mesothelioma. Am J Cancer Res 1: 419-431, 2011.
32. Nasreen N, Khodayari N, Sukka-Ganesh B, Peruvemba S, Mohammed KA. Fluticasone propionate and Salmeterol combination induces SOCS-3 expression in airway epithelial cells. Int Immunopharmacol 12: 217-225, 2012.
33. Nasreen N, Mohammed KA, Antony VB. Silencing the receptor EphA2 suppresses the growth and haptotaxis of malignant mesothelioma cells. Cancer 107: 2425-2435, 2006.
34. Nasreen N, Mohammed KA, Mubarak KK, Baz MA, Akindipe OA, Fernandez-Bussy S, Antony VB. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to TGF-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 297: L115-L124, 2009.
35. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 127: 2525-2532, 2007.
36. Pasquale EB. Eph receptor signalling casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 6: 462-475, 2005.
37. Pratt RL, Kinch MS. Activation of the EphA2 tyrosine kinase stimulates the MAP/ERK kinase signaling cascade. Oncogene 21: 7690-7699, 2002.
38. Puchelle E, Zahm JM, Tournier JM, Coraux C. Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease. Proc Am Thorac Soc 3: 726-733, 2006.
39. Rezaee F, Georas SN. Breaking barriers: new insights into airway epithelial barrier function in health and disease. Am J Respir Cell Mol Biol 2014 Jan 27. [Epub ahead of print]
40. Rusznak C, Mills PR, Devalia JL, Sapsford RJ, Davies RJ, Lozewicz S. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of neversmokers, smokers, and patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 23: 530-536, 2000.
41. Sutherland ER, Martin RJ. Airway inflammation in chronic obstructive pulmonary disease: comparisons with asthma. J Allergy Clin Immunol 112: 819-827; quiz 28, 2003.
42. Tam A, Wadsworth S, Dorscheid D, Man SF, Sin DD. The airway epithelium: more than just a structural barrier. Ther Adv Respir Dis 5: 255-273, 2011.
43. Tanaka M, Kamata R, Sakai R. EphA2 phosphorylates the cytoplasmic tail of Claudin-4 and mediates paracellular permeability. J Biol Chem 280: 42375-42382, 2005.
44. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2: E231-E236, 2000.
45. Vihanto MM, Plock J, Erni D, Frey BM, Frey FJ, Huynh-Do U. Hypoxia up-regulates expression of Eph receptors and ephrins in mouse skin. FASEB J 19: 1689-1691, 2005.
46. Wang X, Wu R, Hao T, Chen F. Effects of cigarette smoke extract on E-cadherin expression in cultured airway epithelial cells. J Tongji Med Univ 20: 32-35, 2000.
47. Zhao J, Harper R, Barchowsky A, Di YP. Identification of multiple MAPKmediated transcription factors regulated by tobacco smoke in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 293: L480-L490, 2007.
48. Zhou N, Zhao WD, Liu DX, Liang Y, Fang WG, Li B, Chen YH. Inactivation of EphA2 promotes tight junction formation and impairs angiogenesis in brain endothelial cells. Microvasc Res 82: 113-21, 2011.